NZ Bans Avandia Over Cardiovascular Concerns
New Zealand's health regulator is pulling diabetes drug Avandia from the shelves, saying a safety review found the medication increased patients' risk of developing cardiovascular problems....To view the full article, register now.
Already a subscriber? Click here to view full article